Inland Presentation of Vibrio Vulnificus Primary Septicemia and Necrotizing Fasciitis
Overview
Authors
Affiliations
In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Tang H, Chang M, Ko W, Huang K, Lee C, Chuang Y Antimicrob Agents Chemother. 2002; 46(11):3580-4.
PMID: 12384368 PMC: 128723. DOI: 10.1128/AAC.46.11.3580-3584.2002.
In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.
Chuang Y, Liu J, Ko W, Lin K, Wu J, Huang K Antimicrob Agents Chemother. 1997; 41(10):2214-7.
PMID: 9333050 PMC: 164095. DOI: 10.1128/AAC.41.10.2214.
Virulent strains of Vibrio vulnificus isolated from estuaries of the United States West Coast.
Kaysner C, Abeyta Jr C, Wekell M, DePaola Jr A, Stott R, Leitch J Appl Environ Microbiol. 1987; 53(6):1349-51.
PMID: 3606112 PMC: 203868. DOI: 10.1128/aem.53.6.1349-1351.1987.
Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.
Janda J, Powers C, Bryant R, Abbott S Clin Microbiol Rev. 1988; 1(3):245-67.
PMID: 3058295 PMC: 358049. DOI: 10.1128/CMR.1.3.245.
Kaysner C, Tamplin M, Wekell M, Stott R, Colburn K Appl Environ Microbiol. 1989; 55(12):3072-9.
PMID: 2619304 PMC: 203225. DOI: 10.1128/aem.55.12.3072-3079.1989.